
Join to view full profile
600 Highland AveMadison, WI 53792
Phone+1 608-263-8443
Fax+1 623-322-4639
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Rogers, MD is a board certified pathologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Louisiana, and Florida. He is affiliated with City of Hope Chicago and is an Assistant Professor at Emory Univ Sch.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Pathology-Anatomic and Clinical, 1988 - 1990
Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 1986 - 1988
Baylor College of MedicineResidency, Internal Medicine, 1984 - 1986
Marshall University School of MedicineInternship, Internal Medicine, 1982 - 1983
University of Texas Medical Branch School of MedicineClass of 1982
Certifications & Licensure
IL State Medical License 2024 - 2029
AZ State Medical License 1984 - 2028
ND State Medical License 2025 - 2028
TN State Medical License 2024 - 2028
TX State Medical License 1993 - 2028
FL State Medical License 2025 - 2027
GA State Medical License 2011 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Pathology Anatomic Pathology & Clinical Pathology- Join now to see all
Publications & Presentations
PubMed
- 55 citationsMetabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and CancerThomas E. Rogers, Ralph J. DeBerardinis
Trends in Cancer. 2021-08-01 - Effectiveness of MB-102, a novel fluorescent tracer agent, for conducting ocular angiography in dogsChristopher G. Pirie, Thomas E. Rogers, Richard B. Dorshow
American Journal of Veterinary Research. 2020-04-28 - 13 citationsCharacterization of MB-102, a New Fluorescent Tracer Agent for Point-of-Care Renal Function Monitoring.Jeng-Jong Shieh, I. Rochelle Riley, Thomas E. Rogers, Lung-Fa Kao, Richard B. Dorshow
Journal of Pharmaceutical Sciences. 2020-02-01

















